Trial Profile

A Pilot Clinical Study of INO-3106 Against Rare Respiratory Tract Tumors

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 Feb 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs INO 3107 (Primary)
Indications Head and neck cancer; Human papillomavirus infections; Recurrent respiratory papillomatosis
Focus Therapeutic Use

Most Recent Events

03 Feb 2020 According to an Inovio Pharmaceuticals media release, data from this trial has been published in the open access scientific journal Vaccines (MDPI). The article is entitled "Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis".
10 Apr 2019 New trial record
03 Apr 2019 According to an Inovio Pharmaceuticals media release, a complete study report is being prepared as a medical publication.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com